Co-Diagnostics Logo

Co-Diagnostics

🇺🇸
CODX
US1897632048

Co-Diagnostics is a US-based biotechnology company specializing in the development of innovative molecular diagnostic solutions. Through its patented CoPrimer™ technology, the company provides precise PCR tests for infectious disease and laboratory diagnostics to enhance accuracy in clinical testing.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
After-Hours
In 70 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Co-Diagnostics report its next quarterly earnings?

Co-Diagnostics is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Co-Diagnostics last report quarterly earnings?

Co-Diagnostics last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -1.46 USD.

How often has Co-Diagnostics beaten expectations?

Co-Diagnostics has beaten analyst EPS estimates in 3 of its last 6 evaluated quarters (beat rate: 50%).

How do I add the Co-Diagnostics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$2.85
Actual:
Q2 2026
Beat
Estimate:-$3.00
Actual:-$1.46
Difference:+$1.54
Q1 2026
Missed
Estimate:-$3.75
Actual:-$4.06
Difference:-$0.31
Price reaction (1 day):-21.2 %
Price reaction (7 days):+127.6 %
Q4 2025
Missed
Estimate:-$3.60
Actual:-$16.35
Difference:-$12.75
Price reaction (1 day):-12.9 %
Price reaction (7 days):-23.7 %
Q3 2025
Missed
Estimate:-$3.60
Actual:-$4.44
Difference:-$0.84
Q2 2025
Beat
Estimate:-$5.70
Actual:-$4.66
Difference:+$1.04
Q1 2025
Beat
Estimate:-$7.50
Actual:-$7.01
Difference:+$0.49

Earnings statistics

Estimates vs. results

3/6
Quarters above estimates
50%
Beat rate
-51.8%
Avg. EPS surprise

Basis: 6 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Co-Diagnostics
Ticker Symbol
CODX
ISIN
US1897632048
Country
🇺🇸
USA
Sector
More Financial Information